Breast, liver, colorectal and non-small cell lung cancer risks declined significantly
It is an investigational drug that is still under phase 3 clinical trials, in which the researchers are evaluating the safety, dosing, efficacy, and long-term outcome in a larger population
For comparison, most injectable peptides have much shorter half-lives requiring more frequent dosing
Nausea, constipation, reflux, appetite changes, and other GLP-1-related effects can still occur
However, these pharmacies are more limited in scale and can make GLP-1s for only a narrow set of reasons, not routine prescriptions
Noretatrutide is not an FDA-approved medication for weight loss or any other condition at the time of writing